nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Estropipate—osteoporosis	0.108	0.181	CbGbCtD
Temozolomide—CYP3A4—Calcitriol—osteoporosis	0.108	0.181	CbGbCtD
Temozolomide—CYP3A4—Ergocalciferol—osteoporosis	0.0863	0.145	CbGbCtD
Temozolomide—CYP3A4—Raloxifene—osteoporosis	0.072	0.121	CbGbCtD
Temozolomide—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0695	0.117	CbGbCtD
Temozolomide—CYP3A4—Cholecalciferol—osteoporosis	0.0556	0.0934	CbGbCtD
Temozolomide—CYP3A4—Conjugated Estrogens—osteoporosis	0.051	0.0858	CbGbCtD
Temozolomide—CYP3A4—Estradiol—osteoporosis	0.0448	0.0753	CbGbCtD
Temozolomide—Palpitations—Conjugated Estrogens—osteoporosis	0.000258	0.000636	CcSEcCtD
Temozolomide—Insomnia—Risedronate—osteoporosis	0.000257	0.000636	CcSEcCtD
Temozolomide—Anxiety—Zoledronate—osteoporosis	0.000257	0.000634	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000256	0.000632	CcSEcCtD
Temozolomide—Paraesthesia—Risedronate—osteoporosis	0.000256	0.000631	CcSEcCtD
Temozolomide—Pruritus—Estropipate—osteoporosis	0.000255	0.000629	CcSEcCtD
Temozolomide—Discomfort—Zoledronate—osteoporosis	0.000255	0.000629	CcSEcCtD
Temozolomide—Asthenia—Alendronate—osteoporosis	0.000255	0.000628	CcSEcCtD
Temozolomide—Hypersensitivity—Ibandronate—osteoporosis	0.000254	0.000628	CcSEcCtD
Temozolomide—Cough—Conjugated Estrogens—osteoporosis	0.000254	0.000628	CcSEcCtD
Temozolomide—Dyspnoea—Risedronate—osteoporosis	0.000254	0.000627	CcSEcCtD
Temozolomide—Erythema multiforme—Estradiol—osteoporosis	0.000253	0.000626	CcSEcCtD
Temozolomide—Convulsion—Conjugated Estrogens—osteoporosis	0.000253	0.000624	CcSEcCtD
Temozolomide—Dry mouth—Zoledronate—osteoporosis	0.000252	0.000623	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	0.000252	0.000622	CcSEcCtD
Temozolomide—Fatigue—Ethinyl Estradiol—osteoporosis	0.000252	0.000621	CcSEcCtD
Temozolomide—Pruritus—Alendronate—osteoporosis	0.000251	0.00062	CcSEcCtD
Temozolomide—Dyspepsia—Risedronate—osteoporosis	0.000251	0.000619	CcSEcCtD
Temozolomide—Eye disorder—Estradiol—osteoporosis	0.000251	0.000619	CcSEcCtD
Temozolomide—Tinnitus—Estradiol—osteoporosis	0.00025	0.000617	CcSEcCtD
Temozolomide—Constipation—Ethinyl Estradiol—osteoporosis	0.00025	0.000616	CcSEcCtD
Temozolomide—Confusional state—Zoledronate—osteoporosis	0.000249	0.000615	CcSEcCtD
Temozolomide—Hypersensitivity—Calcitriol—osteoporosis	0.000249	0.000615	CcSEcCtD
Temozolomide—Flushing—Estradiol—osteoporosis	0.000249	0.000614	CcSEcCtD
Temozolomide—Cardiac disorder—Estradiol—osteoporosis	0.000249	0.000614	CcSEcCtD
Temozolomide—Myalgia—Conjugated Estrogens—osteoporosis	0.000248	0.000613	CcSEcCtD
Temozolomide—Arthralgia—Conjugated Estrogens—osteoporosis	0.000248	0.000613	CcSEcCtD
Temozolomide—Asthenia—Ibandronate—osteoporosis	0.000248	0.000612	CcSEcCtD
Temozolomide—Anxiety—Conjugated Estrogens—osteoporosis	0.000247	0.000611	CcSEcCtD
Temozolomide—Nausea—Etidronic acid—osteoporosis	0.000247	0.000611	CcSEcCtD
Temozolomide—Anaphylactic shock—Zoledronate—osteoporosis	0.000247	0.00061	CcSEcCtD
Temozolomide—Oedema—Zoledronate—osteoporosis	0.000247	0.00061	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	0.000247	0.000609	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Pamidronate—osteoporosis	0.000247	0.000609	CcSEcCtD
Temozolomide—Diarrhoea—Estropipate—osteoporosis	0.000246	0.000609	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Risedronate—osteoporosis	0.000246	0.000607	CcSEcCtD
Temozolomide—Infection—Zoledronate—osteoporosis	0.000246	0.000606	CcSEcCtD
Temozolomide—Fatigue—Risedronate—osteoporosis	0.000245	0.000606	CcSEcCtD
Temozolomide—Insomnia—Pamidronate—osteoporosis	0.000245	0.000604	CcSEcCtD
Temozolomide—Pruritus—Ibandronate—osteoporosis	0.000244	0.000603	CcSEcCtD
Temozolomide—Pain—Risedronate—osteoporosis	0.000243	0.000601	CcSEcCtD
Temozolomide—Constipation—Risedronate—osteoporosis	0.000243	0.000601	CcSEcCtD
Temozolomide—Angiopathy—Estradiol—osteoporosis	0.000243	0.000601	CcSEcCtD
Temozolomide—Paraesthesia—Pamidronate—osteoporosis	0.000243	0.0006	CcSEcCtD
Temozolomide—Diarrhoea—Alendronate—osteoporosis	0.000243	0.000599	CcSEcCtD
Temozolomide—Asthenia—Calcitriol—osteoporosis	0.000243	0.000599	CcSEcCtD
Temozolomide—Nervous system disorder—Zoledronate—osteoporosis	0.000242	0.000598	CcSEcCtD
Temozolomide—Immune system disorder—Estradiol—osteoporosis	0.000242	0.000598	CcSEcCtD
Temozolomide—Thrombocytopenia—Zoledronate—osteoporosis	0.000242	0.000598	CcSEcCtD
Temozolomide—Mediastinal disorder—Estradiol—osteoporosis	0.000242	0.000597	CcSEcCtD
Temozolomide—Dyspnoea—Pamidronate—osteoporosis	0.000241	0.000596	CcSEcCtD
Temozolomide—Feeling abnormal—Ethinyl Estradiol—osteoporosis	0.000241	0.000594	CcSEcCtD
Temozolomide—Chills—Estradiol—osteoporosis	0.000241	0.000594	CcSEcCtD
Temozolomide—Somnolence—Pamidronate—osteoporosis	0.000241	0.000594	CcSEcCtD
Temozolomide—Skin disorder—Zoledronate—osteoporosis	0.00024	0.000593	CcSEcCtD
Temozolomide—Pruritus—Calcitriol—osteoporosis	0.000239	0.000591	CcSEcCtD
Temozolomide—Hyperhidrosis—Zoledronate—osteoporosis	0.000239	0.00059	CcSEcCtD
Temozolomide—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	0.000239	0.000589	CcSEcCtD
Temozolomide—Diarrhoea—Raloxifene—osteoporosis	0.000239	0.000589	CcSEcCtD
Temozolomide—Dyspepsia—Pamidronate—osteoporosis	0.000238	0.000588	CcSEcCtD
Temozolomide—Dizziness—Estropipate—osteoporosis	0.000238	0.000588	CcSEcCtD
Temozolomide—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.000238	0.000588	CcSEcCtD
Temozolomide—Oedema—Conjugated Estrogens—osteoporosis	0.000238	0.000588	CcSEcCtD
Temozolomide—Alopecia—Estradiol—osteoporosis	0.000237	0.000585	CcSEcCtD
Temozolomide—Infection—Conjugated Estrogens—osteoporosis	0.000236	0.000584	CcSEcCtD
Temozolomide—Diarrhoea—Ibandronate—osteoporosis	0.000236	0.000584	CcSEcCtD
Temozolomide—Anorexia—Zoledronate—osteoporosis	0.000236	0.000582	CcSEcCtD
Temozolomide—Decreased appetite—Pamidronate—osteoporosis	0.000235	0.000581	CcSEcCtD
Temozolomide—Mental disorder—Estradiol—osteoporosis	0.000235	0.00058	CcSEcCtD
Temozolomide—Dizziness—Alendronate—osteoporosis	0.000235	0.000579	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Pamidronate—osteoporosis	0.000234	0.000577	CcSEcCtD
Temozolomide—Nervous system disorder—Conjugated Estrogens—osteoporosis	0.000233	0.000576	CcSEcCtD
Temozolomide—Erythema—Estradiol—osteoporosis	0.000233	0.000576	CcSEcCtD
Temozolomide—Malnutrition—Estradiol—osteoporosis	0.000233	0.000576	CcSEcCtD
Temozolomide—Fatigue—Pamidronate—osteoporosis	0.000233	0.000576	CcSEcCtD
Temozolomide—Gastrointestinal pain—Risedronate—osteoporosis	0.000233	0.000575	CcSEcCtD
Temozolomide—Urticaria—Ethinyl Estradiol—osteoporosis	0.000232	0.000573	CcSEcCtD
Temozolomide—Constipation—Pamidronate—osteoporosis	0.000231	0.000571	CcSEcCtD
Temozolomide—Pain—Pamidronate—osteoporosis	0.000231	0.000571	CcSEcCtD
Temozolomide—Diarrhoea—Calcitriol—osteoporosis	0.000231	0.000571	CcSEcCtD
Temozolomide—Skin disorder—Conjugated Estrogens—osteoporosis	0.000231	0.000571	CcSEcCtD
Temozolomide—Abdominal pain—Ethinyl Estradiol—osteoporosis	0.000231	0.00057	CcSEcCtD
Temozolomide—Body temperature increased—Ethinyl Estradiol—osteoporosis	0.000231	0.00057	CcSEcCtD
Temozolomide—Dizziness—Raloxifene—osteoporosis	0.000231	0.00057	CcSEcCtD
Temozolomide—Hyperhidrosis—Conjugated Estrogens—osteoporosis	0.00023	0.000568	CcSEcCtD
Temozolomide—Vomiting—Estropipate—osteoporosis	0.000229	0.000565	CcSEcCtD
Temozolomide—Dysgeusia—Estradiol—osteoporosis	0.000229	0.000564	CcSEcCtD
Temozolomide—Dizziness—Ibandronate—osteoporosis	0.000228	0.000564	CcSEcCtD
Temozolomide—Rash—Estropipate—osteoporosis	0.000227	0.000561	CcSEcCtD
Temozolomide—Dermatitis—Estropipate—osteoporosis	0.000227	0.00056	CcSEcCtD
Temozolomide—Anorexia—Conjugated Estrogens—osteoporosis	0.000227	0.00056	CcSEcCtD
Temozolomide—Urticaria—Risedronate—osteoporosis	0.000226	0.000558	CcSEcCtD
Temozolomide—Back pain—Estradiol—osteoporosis	0.000226	0.000557	CcSEcCtD
Temozolomide—Headache—Estropipate—osteoporosis	0.000226	0.000557	CcSEcCtD
Temozolomide—Vomiting—Alendronate—osteoporosis	0.000226	0.000557	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Zoledronate—osteoporosis	0.000225	0.000556	CcSEcCtD
Temozolomide—Abdominal pain—Risedronate—osteoporosis	0.000225	0.000556	CcSEcCtD
Temozolomide—Body temperature increased—Risedronate—osteoporosis	0.000225	0.000556	CcSEcCtD
Temozolomide—Rash—Alendronate—osteoporosis	0.000224	0.000552	CcSEcCtD
Temozolomide—Insomnia—Zoledronate—osteoporosis	0.000224	0.000552	CcSEcCtD
Temozolomide—Dermatitis—Alendronate—osteoporosis	0.000223	0.000552	CcSEcCtD
Temozolomide—Feeling abnormal—Pamidronate—osteoporosis	0.000223	0.000551	CcSEcCtD
Temozolomide—Headache—Alendronate—osteoporosis	0.000222	0.000549	CcSEcCtD
Temozolomide—Paraesthesia—Zoledronate—osteoporosis	0.000222	0.000548	CcSEcCtD
Temozolomide—Vomiting—Raloxifene—osteoporosis	0.000222	0.000548	CcSEcCtD
Temozolomide—Gastrointestinal pain—Pamidronate—osteoporosis	0.000221	0.000546	CcSEcCtD
Temozolomide—Dyspnoea—Zoledronate—osteoporosis	0.00022	0.000544	CcSEcCtD
Temozolomide—Rash—Raloxifene—osteoporosis	0.00022	0.000543	CcSEcCtD
Temozolomide—Dermatitis—Raloxifene—osteoporosis	0.00022	0.000543	CcSEcCtD
Temozolomide—Somnolence—Zoledronate—osteoporosis	0.00022	0.000543	CcSEcCtD
Temozolomide—Vomiting—Ibandronate—osteoporosis	0.00022	0.000542	CcSEcCtD
Temozolomide—Tremor—Estradiol—osteoporosis	0.000219	0.00054	CcSEcCtD
Temozolomide—Headache—Raloxifene—osteoporosis	0.000219	0.00054	CcSEcCtD
Temozolomide—Rash—Ibandronate—osteoporosis	0.000218	0.000538	CcSEcCtD
Temozolomide—Dermatitis—Ibandronate—osteoporosis	0.000218	0.000537	CcSEcCtD
Temozolomide—Dyspepsia—Zoledronate—osteoporosis	0.000218	0.000537	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	0.000217	0.000535	CcSEcCtD
Temozolomide—Ill-defined disorder—Estradiol—osteoporosis	0.000217	0.000535	CcSEcCtD
Temozolomide—Headache—Ibandronate—osteoporosis	0.000216	0.000534	CcSEcCtD
Temozolomide—Insomnia—Conjugated Estrogens—osteoporosis	0.000215	0.000532	CcSEcCtD
Temozolomide—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.000215	0.000531	CcSEcCtD
Temozolomide—Vomiting—Calcitriol—osteoporosis	0.000215	0.000531	CcSEcCtD
Temozolomide—Decreased appetite—Zoledronate—osteoporosis	0.000215	0.000531	CcSEcCtD
Temozolomide—Agitation—Estradiol—osteoporosis	0.000214	0.00053	CcSEcCtD
Temozolomide—Nausea—Estropipate—osteoporosis	0.000214	0.000528	CcSEcCtD
Temozolomide—Abdominal pain—Pamidronate—osteoporosis	0.000214	0.000528	CcSEcCtD
Temozolomide—Body temperature increased—Pamidronate—osteoporosis	0.000214	0.000528	CcSEcCtD
Temozolomide—Paraesthesia—Conjugated Estrogens—osteoporosis	0.000214	0.000528	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Zoledronate—osteoporosis	0.000213	0.000527	CcSEcCtD
Temozolomide—Angioedema—Estradiol—osteoporosis	0.000213	0.000527	CcSEcCtD
Temozolomide—Rash—Calcitriol—osteoporosis	0.000213	0.000526	CcSEcCtD
Temozolomide—Fatigue—Zoledronate—osteoporosis	0.000213	0.000526	CcSEcCtD
Temozolomide—Dermatitis—Calcitriol—osteoporosis	0.000213	0.000526	CcSEcCtD
Temozolomide—Dyspnoea—Conjugated Estrogens—osteoporosis	0.000212	0.000524	CcSEcCtD
Temozolomide—Headache—Calcitriol—osteoporosis	0.000212	0.000523	CcSEcCtD
Temozolomide—Somnolence—Conjugated Estrogens—osteoporosis	0.000212	0.000522	CcSEcCtD
Temozolomide—Pain—Zoledronate—osteoporosis	0.000211	0.000522	CcSEcCtD
Temozolomide—Constipation—Zoledronate—osteoporosis	0.000211	0.000522	CcSEcCtD
Temozolomide—Nausea—Alendronate—osteoporosis	0.000211	0.00052	CcSEcCtD
Temozolomide—Malaise—Estradiol—osteoporosis	0.00021	0.00052	CcSEcCtD
Temozolomide—Hypersensitivity—Risedronate—osteoporosis	0.00021	0.000518	CcSEcCtD
Temozolomide—Vertigo—Estradiol—osteoporosis	0.00021	0.000518	CcSEcCtD
Temozolomide—Dyspepsia—Conjugated Estrogens—osteoporosis	0.000209	0.000517	CcSEcCtD
Temozolomide—Asthenia—Ethinyl Estradiol—osteoporosis	0.000209	0.000517	CcSEcCtD
Temozolomide—Nausea—Raloxifene—osteoporosis	0.000207	0.000512	CcSEcCtD
Temozolomide—Decreased appetite—Conjugated Estrogens—osteoporosis	0.000207	0.000511	CcSEcCtD
Temozolomide—Pruritus—Ethinyl Estradiol—osteoporosis	0.000207	0.00051	CcSEcCtD
Temozolomide—Palpitations—Estradiol—osteoporosis	0.000206	0.000509	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	0.000205	0.000507	CcSEcCtD
Temozolomide—Fatigue—Conjugated Estrogens—osteoporosis	0.000205	0.000507	CcSEcCtD
Temozolomide—Nausea—Ibandronate—osteoporosis	0.000205	0.000507	CcSEcCtD
Temozolomide—Asthenia—Risedronate—osteoporosis	0.000204	0.000504	CcSEcCtD
Temozolomide—Feeling abnormal—Zoledronate—osteoporosis	0.000204	0.000503	CcSEcCtD
Temozolomide—Cough—Estradiol—osteoporosis	0.000204	0.000503	CcSEcCtD
Temozolomide—Constipation—Conjugated Estrogens—osteoporosis	0.000204	0.000503	CcSEcCtD
Temozolomide—Pain—Conjugated Estrogens—osteoporosis	0.000204	0.000503	CcSEcCtD
Temozolomide—Gastrointestinal pain—Zoledronate—osteoporosis	0.000202	0.000499	CcSEcCtD
Temozolomide—Hypertension—Estradiol—osteoporosis	0.000201	0.000498	CcSEcCtD
Temozolomide—Pruritus—Risedronate—osteoporosis	0.000201	0.000497	CcSEcCtD
Temozolomide—Nausea—Calcitriol—osteoporosis	0.000201	0.000496	CcSEcCtD
Temozolomide—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.0002	0.000493	CcSEcCtD
Temozolomide—Hypersensitivity—Pamidronate—osteoporosis	0.000199	0.000492	CcSEcCtD
Temozolomide—Arthralgia—Estradiol—osteoporosis	0.000199	0.000491	CcSEcCtD
Temozolomide—Myalgia—Estradiol—osteoporosis	0.000199	0.000491	CcSEcCtD
Temozolomide—Anxiety—Estradiol—osteoporosis	0.000198	0.000489	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	0.000197	0.000487	CcSEcCtD
Temozolomide—Urticaria—Zoledronate—osteoporosis	0.000196	0.000485	CcSEcCtD
Temozolomide—Discomfort—Estradiol—osteoporosis	0.000196	0.000485	CcSEcCtD
Temozolomide—Abdominal pain—Zoledronate—osteoporosis	0.000195	0.000482	CcSEcCtD
Temozolomide—Body temperature increased—Zoledronate—osteoporosis	0.000195	0.000482	CcSEcCtD
Temozolomide—Diarrhoea—Risedronate—osteoporosis	0.000195	0.000481	CcSEcCtD
Temozolomide—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	0.000195	0.000481	CcSEcCtD
Temozolomide—Dry mouth—Estradiol—osteoporosis	0.000194	0.00048	CcSEcCtD
Temozolomide—Asthenia—Pamidronate—osteoporosis	0.000194	0.000479	CcSEcCtD
Temozolomide—Dizziness—Ethinyl Estradiol—osteoporosis	0.000193	0.000477	CcSEcCtD
Temozolomide—Confusional state—Estradiol—osteoporosis	0.000192	0.000474	CcSEcCtD
Temozolomide—Pruritus—Pamidronate—osteoporosis	0.000191	0.000473	CcSEcCtD
Temozolomide—Oedema—Estradiol—osteoporosis	0.00019	0.00047	CcSEcCtD
Temozolomide—Anaphylactic shock—Estradiol—osteoporosis	0.00019	0.00047	CcSEcCtD
Temozolomide—Infection—Estradiol—osteoporosis	0.000189	0.000467	CcSEcCtD
Temozolomide—Urticaria—Conjugated Estrogens—osteoporosis	0.000189	0.000467	CcSEcCtD
Temozolomide—Dizziness—Risedronate—osteoporosis	0.000188	0.000465	CcSEcCtD
Temozolomide—Body temperature increased—Conjugated Estrogens—osteoporosis	0.000188	0.000465	CcSEcCtD
Temozolomide—Abdominal pain—Conjugated Estrogens—osteoporosis	0.000188	0.000465	CcSEcCtD
Temozolomide—Nervous system disorder—Estradiol—osteoporosis	0.000187	0.000461	CcSEcCtD
Temozolomide—Vomiting—Ethinyl Estradiol—osteoporosis	0.000186	0.000458	CcSEcCtD
Temozolomide—Diarrhoea—Pamidronate—osteoporosis	0.000185	0.000457	CcSEcCtD
Temozolomide—Skin disorder—Estradiol—osteoporosis	0.000185	0.000457	CcSEcCtD
Temozolomide—Hyperhidrosis—Estradiol—osteoporosis	0.000184	0.000455	CcSEcCtD
Temozolomide—Rash—Ethinyl Estradiol—osteoporosis	0.000184	0.000455	CcSEcCtD
Temozolomide—Dermatitis—Ethinyl Estradiol—osteoporosis	0.000184	0.000454	CcSEcCtD
Temozolomide—Headache—Ethinyl Estradiol—osteoporosis	0.000183	0.000452	CcSEcCtD
Temozolomide—Hypersensitivity—Zoledronate—osteoporosis	0.000182	0.00045	CcSEcCtD
Temozolomide—Vomiting—Risedronate—osteoporosis	0.000181	0.000447	CcSEcCtD
Temozolomide—Rash—Risedronate—osteoporosis	0.000179	0.000443	CcSEcCtD
Temozolomide—Dermatitis—Risedronate—osteoporosis	0.000179	0.000443	CcSEcCtD
Temozolomide—Dizziness—Pamidronate—osteoporosis	0.000179	0.000442	CcSEcCtD
Temozolomide—Headache—Risedronate—osteoporosis	0.000178	0.00044	CcSEcCtD
Temozolomide—Asthenia—Zoledronate—osteoporosis	0.000177	0.000438	CcSEcCtD
Temozolomide—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.000175	0.000433	CcSEcCtD
Temozolomide—Pruritus—Zoledronate—osteoporosis	0.000175	0.000432	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Estradiol—osteoporosis	0.000174	0.000428	CcSEcCtD
Temozolomide—Nausea—Ethinyl Estradiol—osteoporosis	0.000173	0.000428	CcSEcCtD
Temozolomide—Insomnia—Estradiol—osteoporosis	0.000172	0.000425	CcSEcCtD
Temozolomide—Vomiting—Pamidronate—osteoporosis	0.000172	0.000425	CcSEcCtD
Temozolomide—Paraesthesia—Estradiol—osteoporosis	0.000171	0.000422	CcSEcCtD
Temozolomide—Asthenia—Conjugated Estrogens—osteoporosis	0.000171	0.000422	CcSEcCtD
Temozolomide—Rash—Pamidronate—osteoporosis	0.000171	0.000421	CcSEcCtD
Temozolomide—Dermatitis—Pamidronate—osteoporosis	0.00017	0.000421	CcSEcCtD
Temozolomide—Dyspnoea—Estradiol—osteoporosis	0.00017	0.000419	CcSEcCtD
Temozolomide—Headache—Pamidronate—osteoporosis	0.00017	0.000419	CcSEcCtD
Temozolomide—Somnolence—Estradiol—osteoporosis	0.000169	0.000418	CcSEcCtD
Temozolomide—Diarrhoea—Zoledronate—osteoporosis	0.000169	0.000418	CcSEcCtD
Temozolomide—Nausea—Risedronate—osteoporosis	0.000169	0.000417	CcSEcCtD
Temozolomide—Pruritus—Conjugated Estrogens—osteoporosis	0.000168	0.000416	CcSEcCtD
Temozolomide—Dyspepsia—Estradiol—osteoporosis	0.000168	0.000414	CcSEcCtD
Temozolomide—Decreased appetite—Estradiol—osteoporosis	0.000166	0.000409	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Estradiol—osteoporosis	0.000164	0.000406	CcSEcCtD
Temozolomide—Fatigue—Estradiol—osteoporosis	0.000164	0.000405	CcSEcCtD
Temozolomide—Dizziness—Zoledronate—osteoporosis	0.000163	0.000404	CcSEcCtD
Temozolomide—Pain—Estradiol—osteoporosis	0.000163	0.000402	CcSEcCtD
Temozolomide—Constipation—Estradiol—osteoporosis	0.000163	0.000402	CcSEcCtD
Temozolomide—Diarrhoea—Conjugated Estrogens—osteoporosis	0.000163	0.000402	CcSEcCtD
Temozolomide—Nausea—Pamidronate—osteoporosis	0.000161	0.000397	CcSEcCtD
Temozolomide—Dizziness—Conjugated Estrogens—osteoporosis	0.000157	0.000389	CcSEcCtD
Temozolomide—Vomiting—Zoledronate—osteoporosis	0.000157	0.000388	CcSEcCtD
Temozolomide—Feeling abnormal—Estradiol—osteoporosis	0.000157	0.000388	CcSEcCtD
Temozolomide—Rash—Zoledronate—osteoporosis	0.000156	0.000385	CcSEcCtD
Temozolomide—Gastrointestinal pain—Estradiol—osteoporosis	0.000156	0.000385	CcSEcCtD
Temozolomide—Dermatitis—Zoledronate—osteoporosis	0.000156	0.000384	CcSEcCtD
Temozolomide—Headache—Zoledronate—osteoporosis	0.000155	0.000382	CcSEcCtD
Temozolomide—Vomiting—Conjugated Estrogens—osteoporosis	0.000151	0.000374	CcSEcCtD
Temozolomide—Urticaria—Estradiol—osteoporosis	0.000151	0.000374	CcSEcCtD
Temozolomide—Abdominal pain—Estradiol—osteoporosis	0.000151	0.000372	CcSEcCtD
Temozolomide—Body temperature increased—Estradiol—osteoporosis	0.000151	0.000372	CcSEcCtD
Temozolomide—Rash—Conjugated Estrogens—osteoporosis	0.00015	0.000371	CcSEcCtD
Temozolomide—Dermatitis—Conjugated Estrogens—osteoporosis	0.00015	0.00037	CcSEcCtD
Temozolomide—Headache—Conjugated Estrogens—osteoporosis	0.000149	0.000368	CcSEcCtD
Temozolomide—Nausea—Zoledronate—osteoporosis	0.000147	0.000363	CcSEcCtD
Temozolomide—Nausea—Conjugated Estrogens—osteoporosis	0.000141	0.000349	CcSEcCtD
Temozolomide—Hypersensitivity—Estradiol—osteoporosis	0.00014	0.000347	CcSEcCtD
Temozolomide—Asthenia—Estradiol—osteoporosis	0.000137	0.000337	CcSEcCtD
Temozolomide—Pruritus—Estradiol—osteoporosis	0.000135	0.000333	CcSEcCtD
Temozolomide—Diarrhoea—Estradiol—osteoporosis	0.00013	0.000322	CcSEcCtD
Temozolomide—Dizziness—Estradiol—osteoporosis	0.000126	0.000311	CcSEcCtD
Temozolomide—Vomiting—Estradiol—osteoporosis	0.000121	0.000299	CcSEcCtD
Temozolomide—Rash—Estradiol—osteoporosis	0.00012	0.000297	CcSEcCtD
Temozolomide—Dermatitis—Estradiol—osteoporosis	0.00012	0.000296	CcSEcCtD
Temozolomide—Headache—Estradiol—osteoporosis	0.000119	0.000295	CcSEcCtD
Temozolomide—Nausea—Estradiol—osteoporosis	0.000113	0.000279	CcSEcCtD
